🔗 Permalink

Inventor profile of:

Mark D. HEIPEL

City:

Seattle, Washington

Country:

United States

Published Applications:

11

Last publication date:

2024-01-18

Top Assignees for applications by Mark D. HEIPEL

The entities that hold a legal rights for patent applications filed by inventor HEIPEL Mark D.:

Juno Therapeutics, Inc. 3 Seattle, WA United States

Recent patent applications by HEIPEL Mark D.

Mark D. HEIPEL from Seattle, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-01-18

US20240018268A1

Chemistry; metallurgy

ANTI-IDIOTYPIC ANTIBODIES AGAINST ANTI-CD19 ANTIBODIES

#2 | 2021-07-01

US20210198372A1

Chemistry; metallurgy

METHODS FOR DOSING AND FOR MODULATION OF GENETICALLY ENGINEERED CELLS

#3 | 2020-03-12

US20200078400A1

Human necessities

METHODS FOR DETERMINING CAR-T CELLS DOSING

#4 | 2011-12-08

US20110300098A1

Chemistry; metallurgy

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#5 | 2011-04-14

US20110086004A1

Chemistry; metallurgy

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#6 | 2009-10-29

US20090269304A1

Chemistry; metallurgy

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#7 | 2009-04-02

US20090087404A1

Chemistry; metallurgy

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#8 | 2007-08-02

US20070178063A1

Chemistry; metallurgy

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#9 | 2007-05-31

US20070122382A1

Chemistry; metallurgy

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#10 | 2007-03-01

US20070048264A1

Chemistry; metallurgy

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#11 | 2005-12-01

US20050265966A1

Chemistry; metallurgy

Methods of treating cancer using IL-21 and monoclonal antibody therapy

InventorID:

2668517 ⎘